Síndrome de Fisher-Bickerstaff: espectro clínico del anti-GQ1b

Fisher, 1956, An unusual variant of acute idiopathic polyneuritis (syndrome of ophthalmoplegia, ataxia and areflexia), N Engl J Med, 255, 57, 10.1056/NEJM195607122550201 Mori, 2011, Fisher syndrome, Curr Treat Options Neurol, 13, 71, 10.1007/s11940-010-0103-8 Mori, 2001, Clinical features and prognosis of Miller Fisher syndrome, Neurology, 56, 1104, 10.1212/WNL.56.8.1104 Odaka, 2001, Anti-GQ1b IgG antibody syndrome: Clinical and inmmunological spectrum, J Neurol Neurosurg Psychiatry, 70, 50, 10.1136/jnnp.70.1.50 Chiba, 1992, Serum IgG antibody to ganglioside GQ1b is a possible marker of Miller Fisher syndrome, Ann Neurol, 31, 677, 10.1002/ana.410310619 Chiba, 1993, Serum anti-GQ1b IgG antibody is associated with ophthalmoplegia in Miller Fisher syndrome and Guillain-Barré syndrome: Clinical and immunohistochemical studies, Neurology, 43, 1911, 10.1212/WNL.43.10.1911 Yuki, 1994, Molecularmimicrym between GQ1b ganglioside and lipopolysaccharides of Campylobacter jejuni isolated from patients with Fisher's syndrome, Ann Neurol, 36, 791, 10.1002/ana.410360517 Koga, 2001, Miller Fisher syndrome and Haemophilus influenzae infection, Neurology, 57, 686, 10.1212/WNL.57.4.686 Hahn, 1998, Guillain-Barré syndrome, Lancet, 352, 635, 10.1016/S0140-6736(97)12308-X -Liu, 2009, Immunolocalization of GQ1b and related gangliosides in human extraocular neuromuscular junctions and muscle spindles, Invest Ophthalmol Vis Sci, 50, 3226, 10.1167/iovs.08-3333 Sejvar, 2011, Population incidence of Guillain-Barré syndrome: A systematic review and meta-analysis, Neuroepidemiology, 36, 123, 10.1159/000324710 Ropper, 1992, The Guillain-Barré syndrome, N Engl J Med, 326, 1130, 10.1056/NEJM199204233261706 Pascuzzi, 2009, Peripheral neuropathy, Med Clin N Am, 93, 317, 10.1016/j.mcna.2008.12.001 Yuki, 2012, Guillain-Barré syndrome, N Engl J Med, 366, 2294, 10.1056/NEJMra1114525 Aranyi, 2012, Miller Fisher syndrome: Brief overview and update with a focus on electrophysiological findings, Eur J Neurol, 1, 15, 10.1111/j.1468-1331.2011.03445.x San-Juan, 2009, Miller Fisher syndrome: 10 years’ experience in a third-level center, Eur Neurol, 62, 149, 10.1159/000226599 Lo, 2007, Clinical and immunological spectrum of the Miller Fisher syndrome, Muscle Nerve, 36, 615, 10.1002/mus.20835 Ito, 2008, Bickerstaff's brainstem encephalitis and Fisher syndrome form a continuous spectrum. Clinical analysis of 581 cases, J Neurol, 255, 674, 10.1007/s00415-008-0775-0 Arcila-Londono, 2012, Guillain-Barré syndrome, Semin Neurol, 32, 179, 10.1055/s-0032-1329196 Lee, 2008, Acute ophthalmoplegia (without ataxia) associated with anti-GQ1b antibody, Neurology, 71, 426, 10.1212/01.wnl.0000324266.95814.74 Tezer, 2002, Involvement of the central nervous system in Miller Fisher syndrome: A case report, Clin Neurol Neurosur, 104, 377, 10.1016/S0303-8467(02)00016-1 Kimoto, 2006, Relationship of bacterial strains to clinical syndromes of Campylobacter associated neuropathies, Neurology, 67, 1837, 10.1212/01.wnl.0000244468.22377.6b Yuki, 2009, Fisher syndrome and Bickerstaff brainstem encephalitis (Fisher-Bickerstaff syndrome), J Neuroimmune, 215, 1, 10.1016/j.jneuroim.2009.05.020 Arakawa, 1993, The use of intravenous immunoglobulin in Miller Fisher syndrome, Brain Dev, 15, 231, 10.1016/0387-7604(93)90071-F Zifko, 1994, High dose immunoglobulin therapy is effective in the Miller Fisher syndrome, J Neurol, 241, 178, 10.1007/BF00868348 Mori, 2007, Intravenous immunoglobulin therapy for Miller Fisher syndrome, Neurology, 68, 1144, 10.1212/01.wnl.0000258673.31824.61 Overell, 2007, Treatment for Fisher syndrome, Bickerstaff's brainstem encephalitis and related disorders, Cochrane Database Syst Rev, CD004761 Donofrio, 2009, Consensus statement: The use of intravenous immunoglobulin in the treatment of neuromuscularconditions report of the AANEM ad hoc committee, Muscle Nerve, 40, 890, 10.1002/mus.21433 Sauron, 1984, Miller Fisher syndrome: Clinical and electrophysiologic evidence of peripheral origin in 10 cases, Neurology, 34, 953, 10.1212/WNL.34.7.953 Jamal, 1988, The localization of the lesion in patients with acute ophthalmoplegia, ataxia and areflexia (Miller Fisher syndrome). A serial multimodal neurophysiological study, Brain, 111, 95, 10.1093/brain/111.1.95 Fross, 1987, Neuropathy in the Miller Fisher syndrome: clinical and electrophysiologic findings, Neurology, 37, 1493, 10.1212/WNL.37.9.1493 Kusunoki, 1999, Anti-GQ1b antibody is associated with ataxia as well as ophthalmoplegia, Muscle Nerve, 22, 1071, 10.1002/(SICI)1097-4598(199908)22:8<1071::AID-MUS10>3.0.CO;2-0 Kuwabara, 1999, Special sensory ataxia in Miller Fisher syndrome detected by postural body sway analysis, Ann Neurol, 45, 533, 10.1002/1531-8249(199904)45:4<533::AID-ANA19>3.0.CO;2-H Willison, 2008, The role of complement and complement regulators in mediating motor nerve terminal injury in murine models of Guillain-Barre’ syndrome, J Neuroimmunol, 202, 172, 10.1016/j.jneuroim.2008.05.028 Lo, 2003, Acute ophthalmoparesis with anti-GQ1b antibody: Electrophysiological evidence of neuromuscular transmission defect in the orbicularis oculi, J Neurol Neurosurg Psychiatry, 75, 436, 10.1136/jnnp.2003.023630 Lo, 2007, Cortico-hypoglossal and corticospinal conduction abnormality in Bickerstaff's brainstem encephalitis, Clin Neurol Neurosurg, 109, 523, 10.1016/j.clineuro.2007.03.006 Goldberg-Stern, 1994, Abnormal evoked potentials in Miller Fisher syndrome: Further evidence of combined peripheral and central demyelination, J Neurol Neurosurg Psychiatry, 57, 506, 10.1136/jnnp.57.4.506